Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice

Atherosclerosis

Volumn 164, Issue 2, 2002, Pages 251-259

  Rosenfeld, Michael E ^a   Kauser, Katalin ^a   Martin McNulty, Baby ^a   Polinsky, Patti ^a   Schwartz, Stephen M ^a   Rubanyi, Gabor M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein E deficient mice; Atherosclerosis; Estrogen; Intra plaque hemorrhage

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; PLACEBO;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; BLEEDING; BRACHIOCEPHALIC TRUNK; CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; ESTROGEN THERAPY; FEMORAL ARTERY; HEALING; HYPERLIPOPROTEINEMIA TYPE 3; ILIAC ARTERY; MALE; MOUSE; NONHUMAN; POPLITEAL ARTERY; PRIORITY JOURNAL; THORACIC AORTA; VASCULARIZATION;

ALKALINE PHOSPHATASE; ANIMALS; APOLIPOPROTEINS A; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BRACHIOCEPHALIC TRUNK; CHOLESTEROL; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; ESTRADIOL; HEMORRHAGE; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED STRAINS; PROBABILITY; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 0036801741     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00178-8     Document Type: Article

References (31)

1. Bush T.L. The epidemiology of cardiovascular disease in postmenopausal women. Ann. New York Acad. Sci. 592:1990;263-271.
2. Hough J.L., Zilversmit D.B. Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 6:1986;57-63.
3. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys: Lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057.
4. Kushwaha R.S., Lewis D.S., Carey K.D., et al. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (papio sp.). Arterioscler. Thromb. 11:1991;23-31.
5. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) research group. J. Am. Med. Assoc. 280:1998;605-613.
6. Herrington D.M., Reboussin D.M., Brosnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. New Engl. J. Med. 343:2000;522-529.
7. Nabulsi A.A., Folsom A.R., Szklo M., et al. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 94:1996;1857-1863.
8. Hanke H., Kamenz J., Hanke S., et al. Effect of 17-β estradiol on pre-existing atherosclerotic lesions: Role of the endothelium. Atherosclerosis. 147:1999;123-132.
9. Williams J.K., Anthony M.S., Honore E.K., et al. Regression of atherosclerosis in female monkeys. Arterioscler. Thromb. Vasc. Biol. 15:1995;827-836.
10. Haarbo J., Christiansen C. The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits. Atherosclerosis. 123:1996;139-144.
11. Tse J., Martin-McNaulty B., Halks-Miller M., et al. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol. Atherosclerosis. 144:1999;303-313.
12. Nakashima Y., Plump A.S., Raines E.W., et al. Apo E deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:1994;133-140.
13. Seo H.S., Lombardi D.M., Polinsky P., et al. Peripheral vascular stenosis in apolipoprotein-E deficient mice: Potential roles of medial atrophy and adventitial inflammation. Arterioscler. Thromb. Vasc. Biol. 17:1997;3593-3601.
14. Rosenfeld M.E., Polinsky P., Virmani R., et al. Advanced atherosclerotic lesions in the innominate artery of the apo E knockout mouse. Arterioscler. Thromb. Vasc. Biol. 20:2000;2587-2592.
15. Bourassa P.K., Milos P.M., Gaynor B.J., et al. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;10022-10027.
16. Elhage R., Arnal J.F., Pieraggi M.T., et al. 17β-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 17:1997;2679-2684.
17. Reckless J., Metcalfe J.C., Grainger D.J. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. Circulation. 95:1997;1542-1548.
18. Movat H.Z. Demonstration of all connective tissue components in a single section. Arch. Pathol. 60:1955;289-295.
19. Nathan L., Shi W., Dinh H., Mukherjee T.K., Wang X., Lusis A.J., Chaudhuri G. Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase. Proc. Natl. Acad. Sci. USA. 98:2001;3589-3593.
20. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
21. Cummings S.R., Browner W.S., Bauer D., Stone K., Ensrud K., Jamal S., Ettinger B. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. New Engl. J. Med. 339:1998;733-738.
22. Stary H.C., Chandler A.B., Glagov S., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1995;1512-1531.
23. Marsh M.M., Walker V.R., Curtiss L.K., et al. Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J. Lipid Res. 40:1999;893-900.
24. Elhage R., Bayard F., Richard V., et al. Prevention of fatty streak formation by 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation. 96:1997;3048-3052.
25. Iafrati M.D., Karas R.H., Aronovitz M., et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3:1997;545-548.
26. Ralston S.H., Russel R.G., Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res. 5:1990;983-988.
27. Caulin-Glaser T., Watson C.A., Pardi R., et al. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 98:1996;36-42.
28. Frazier-Jensen M.R., Kovacs E.J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154:1995;1838-1845.
29. Pervin S., Singh R., Tong L., et al. Estradiol inhibits the expression and production of monocyte chemotactic protein-1 in vivo. Arterioscler. Thromb. Vasc. Biol. 18:1998;1575-1582.
30. Wagner J.D., Clarkson T.B., St. Clair R.W., et al. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomologous monkeys. J. Clin. Invest. 88:1991;1995-2002.
31. Walsh B.A., Mullick A.E., Walzem R.L., et al. 17β-Estradiol reduces tumor necrosis factor-α-mediated LDL accumulation in the artery wall. J. Lipid Res. 40:1999;387-396.